CHINA HONGGUANG (08646) has appointed Lighigh as a financial advisor for its potential transfer listing.
China Hongguang (08646) announced that on June 12, 2026, the company officially signed a financial advisor appointment letter with Lige Enterprise Financing Limited. Lige has been appointed as a potential listing advisor for the company, providing professional advice on the feasibility and timetable of a potential listing. The appointment of Lige marks a solid step forward in the strategic process of a potential listing.
CHINA HONGGUANG (08646) has announced that the company officially signed a financial advisor appointment letter with Linkage Enterprise Financing Limited on June 12, 2026, appointing Linkage as the financial advisor for the possible transfer listing, providing professional advice on the feasibility and timetable of the possible transfer listing. The appointment of Linkage signifies a solid step forward in the strategic process of possible transfer listing.
As of the date of this announcement, the possible transfer listing is still in the preliminary stage, and the company has not yet submitted a formal application to the Stock Exchange for the possible transfer listing. The company will continue to seek the professional advice of other consultants and organizations related to the possible transfer listing, in order to establish the eligibility and suitability of the possible transfer listing, as well as assess the feasibility of the various conditions of the possible transfer listing.
Related Articles

Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?

New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.

How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!
Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?

New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.

How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!

RECOMMEND





